SCHEMBL4894579

SCHEMBL4894579

CCN(Sc1ccc(-c2ccccc2)nn1)S(=O)(=O)c1ccc(C)c(C(=O)O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
LMNA P02545 5/20 0.40
HPGD P15428 5/20 0.40
MAPT P10636 4/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
ALDH1A1 P00352 5/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
HCRTR1 O43613 1/20 0.38
PKM P14618 1/20 0.38
KDM4E B2RXH2 2/20 0.37
ALOX15 P16050 1/20 0.37
HSD17B10 Q99714 1/20 0.37
POLB P06746 1/20 0.37
SLC12A5 Q9H2X9 2/20 0.37
CYP2D6 P10635 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906202 0.91 RAB9A (0.44) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL4905834 0.89 MAPT (0.39) NPC1RAB9ASMN1; SMN2LMNAHPGD
SCHEMBL4906794 0.82 NPC1 (0.42) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL4902616 0.82 RXFP1 (0.37) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL4906179 0.77 MEN1 (0.44) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL4899232 0.77 GRK6 (0.42) SMN1; SMN2MEN1KMT2ALMNAHPGD
SCHEMBL4906539 0.75 ALDH1A1 (0.42) RAB9AMEN1KMT2ALMNAALDH1A1
SCHEMBL4894575 0.75 LMNA (0.54) NPC1RAB9ASMN1; SMN2KMT2ALMNA
SCHEMBL4903896 0.74 LMNA (0.46) SMN1; SMN2LMNAHPGDALDH1A1ALOX15
SCHEMBL4902449 0.74 TSHR (0.44) NPC1RAB9ASMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD NPC1 59/4885RAB9A 2271/4885SMN1; SMN2 3404/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD NPC1 59/4885RAB9A 2271/4885SMN1; SMN2 3404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.